Antibody gene therapy with adeno-associated viral vectors
OwnerScott Koeniginventor
Life of this patent
Estimating the term…
Loading patent…
OwnerScott Koeniginventor
Estimating the term…
Methods are disclosed for treating and/or preventing diseases, both infectious and chronic. Infectious diseases combated by the methods disclosed herein include microbial caused diseases, especially diseases of the respiratory system, including those diseases caused, induced or otherwise mediated by viruses, bacteria, fungi and other parasites. The present invention also discloses vectors useful in the treatment and/or prevention of such conditions. The vectors disclosed herein are recombinant viral vectors comprising genetically engineered adeno-associated viruses comprising genetic sequences coding for antibody molecules and portions thereof, which antibodies are useful in combating or preventing infectious and chronic diseases, such as respiratory diseases, including asthma, as well as ophthalmic diseases, including age related and diabetes-related macular degeneration and other retinopathies.
A recombinant adeno-associated virus (rAAV) vector whose genome comprises one or more polynucleotide sequences encoding at least one polypeptide of an antibody wherein said polynucleotide is operably linked to control elements that direct intracellular transcription and translation of said polynucleotide when said rAAV is inserted into a mammalian cell.
Dependencies are inferred from the claim text.